Skip to main content
. Author manuscript; available in PMC: 2022 Sep 14.
Published in final edited form as: J Pharm Drug Deliv Res. 2020 Dec 21;10(1):1000197.

Table 1:

Classification and regulatory pathways for approved diabetic wound products.

Product Description Classification Regulatory pathway
TegasorbTM Hydrocolloid dressing Device 510 (K) pre-market notification
Hyalomatrix® Hyaluronic acid derivative hydrogel Device 510 (K) pre-market notification
Regranex® Hydrogel with platelet derived growth factor Drug NDA
DermACELL® Acellular human cadaver derived matrix Device HCT/P
ActicoatTM Silver incorporated polymer matrix Combination device, FRO 510 (K) pre-market notification